20 completed, 6 unknown, 5 terminated, 2 recruiting. 12 Phase 4, 7 Phase 2, 6 Phase 1, 5 Not applicable, 3 Phase 3.
Follow Renal Transplant Rejection: new trials by email Literature Review of Renal Transplant Rejection trials Research Report on Renal Transplant Rejection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-Parametric MRI for Renal Transplantation Magnetic Resonance Imaging - Renal Transplant Rejection | Not yet recruiting | University of Minnesota | 140 | 2027-07-01 | 2026-09-16 | |
| Deep Phenotyping of the Renal Allograft to Prognosticate Clinical Outcomes Renal Transplant Rejection | Withdrawn | University of Pittsburgh | 2026-04-01 | 2026-11-05 | ||
| Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies Rabbit Anti thymocyte globulin (rATG), Basiliximab - Renal Transplant Rejection, Induction Therapy | Phase 3 | Recruiting | University Hospital, Tours | 244 | 2023-11-07 | 2026-06-18 |
| NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation Tacrolimus - Renal Transplant Rejection, Renal Transplant Infection | Phase 1 / Phase 2 | Withdrawn | University College, London | 2023-02-20 | 2023-05-11 | |
| Torque Teno Virus: A Biomarker of Immunosuppression None Observational study - Renal Transplant Rejection, Immunosuppression | Completed | Queen Mary University of London | 268 | 2022-02-15 | 2026-02-23 | |
| Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant BIC/F/TAF 50Mg-200Mg-25Mg Tablet - HIV Infections, Renal Transplant Rejection | Phase 4 | Completed | Weill Medical College of Cornell University | 20 | 2020-11-09 | 2025-08-12 |
| Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor Donor CD34+ and CD3+ cells - Renal Transplant Rejection, Tolerance | Phase 1 / Phase 2 | Recruiting | Jeffrey Veale, MD | 15 | 2019-11-06 | 2026-05-08 |
| Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection Fostamatinib - Renal Transplant Rejection | Phase 1 / Phase 2 | Active not recruiting | Imperial College London | 8 | 2019-05-08 | 2024-11-25 |
| Heme Arginate in Transplantation Study Heme Arginate 25 MG/ML, 0.9% Sodium-chloride - Renal Transplant Rejection, Renal Transplant Failure | Phase 3 | Terminated | University of Edinburgh | 47 | 2019-03-12 | 2025-11-17 |
| Pathology and Imaging in Kidney Allografts Multi-parametric renal MRI - Renal Transplant Rejection, Chronic Kidney Diseases | Terminated | NHS Greater Glasgow and Clyde | 29 | 2019-02-15 | 2022-06-03 | |
| Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation Tacrolimus Extended Release Oral Tablet, Tacrolimus - Renal Transplant Rejection, Kidney Transplant Failure and Rejection | Phase 4 | Completed | Columbia University | 50 | 2018-07-26 | 2024-07-17 |
| Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection Sonazoid, contrast enhanced ultrasonography - Renal Transplant Rejection | Phase 2 | Completed | Brigham and Women's Hospital | 8 | 2018-05-30 | 2023-03-06 |
| Dose Adjustment of Tacrolimus Based on Home Sampling in Renal Transplant Recipients Micro sampling - Renal Transplant Rejection | Completed | Oslo University Hospital | 27 | 2018-04-04 | 2019-08-28 | |
| Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients Prograf, Tacrolimus - Renal Transplant Rejection | Phase 4 | Completed | University of California, Los Angeles | 176 | 2018-03-01 | 2023-04-28 |
| Urine CXCL10 Chemokine Monitoring Post-renal Transplant Rejection treatment according to clinical standard-of-care - Renal Transplant Rejection | Not applicable | Completed | University Hospital, Basel, Switzerland | 241 | 2017-09-28 | 2022-08-11 |
| VIRTUUS Children's Study Renal Transplant Rejection, Pediatric Kidney Disease | Completed | Children's Hospital of Philadelphia | 445 | 2017-08-10 | 2026-07-06 | |
| ALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation Mixed lymphocyte reaction - Renal Transplant Rejection, Immune Repertoire | Unknown | Medical University of Vienna | 50 | 2017-07-01 | 2023-10-23 | |
| MRI in Renal Transplantation Magnetic resonance imaging - End Stage Renal Disease, Renal Transplant Rejection | Unknown | NHS Greater Glasgow and Clyde | 20 | 2017-04-11 | 2018-10-15 | |
| Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI) Antithymocyte Immunoglobulin (Rabbit) - Renal Transplant Rejection | Phase 2 | Completed | Prof. Dr. Petra Reinke | 68 | 2016-12-15 | 2021-01-29 |
| A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death mesenchymal stem cell - Disorder Related to Renal Transplantation, Renal Transplant Rejection | Phase 1 | Unknown | Qipeng Sun | 260 | 2016-01-01 | 2015-07-03 |
Showing 20 of 37. Sign in to see all of them.
Rejection, Psychology (5) · Kidney Failure, Chronic (3) · Fibrosis (2) · Renal Insufficiency, Chronic (2) · Delayed Graft Function (1) · HIV Infections (1) · HIV Seropositivity (1) · Kidney Diseases (1)
Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Behavior (5) · Social Behavior (5) · Urogenital Diseases (5) · Chronic Disease (4) · Disease Attributes (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4) · Renal Insufficiency (4) · Urologic Diseases (4) · Kidney Diseases (3) · Renal Insufficiency, Chronic (2) · Blood-Borne Infections (1)
Tacrolimus (5) · Antilymphocyte Serum (3) · Mycophenolic Acid (3) · Basiliximab (2) · Everolimus (2) · Magnetic Resonance Imaging (2) · Rituximab (2) · Abatacept (1) · Adrenal Cortex Hormones (1) · Blood Specimen Collection (1) · Bortezomib (1) · Control Groups (1) · Cyclosporine (1) · Demography (1) · Drugs, Generic (1)
NHS Greater Glasgow and Clyde (2) · University of California, Los Angeles (2) · Andre Barreto Pereira (1) · Assistance Publique - Hôpitaux de Paris (1) · Brigham and Women's Hospital (1) · Children's Hospital of Philadelphia (1) · Columbia University (1) · E. Steve Woodle (1) · Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1) · Fuzhou General Hospital (1) · Imperial College London (1) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1) · Jeffrey Veale, MD (1) · Leiden University Medical Center (1) · Loma Linda University (1)
United States (15) · United Kingdom (5) · France (3) · Brazil (2) · Spain (2) · Austria (1) · Canada (1) · China (1) · Germany (1) · India (1) · Mexico (1) · Netherlands (1) · Norway (1) · Portugal (1) · Switzerland (1)
E. Steve Woodle, MD (2) · Adele Rike, PharmD (1) · Alastair J Rankin, MBChB (1) · Andre B Pereira, PhD (1) · Aravind Cherukuri, MD (1) · Aruna Rakha, PhD. (1) · Brendan Keating, DPhil (1) · Catherine B Small, MD (1) · Domingo Hernandez, PhD (1) · Elias David-Neto, PhD (1) · Flavio Vincenti, M.D. (1) · Frederick Tam, MBBChir (1) · Heike E Daldrup-Link, MD, PhD (1) · Jeffrey Veale, MD (1) · Jianming Tan, M.D and Ph.D (1)
PMID 11045649, PMID 15192134, PMID 22081892, PMID 22436957, PMID 23009139, PMID 23349326, PMID 25386950, PMID 25491391, PMID 29145879, PMID 29514693, PMID 30229398, PMID 30903722, PMID 31335773, PMID 31477052, PMID 32775820, PMID 33947168, PMID 34067039, PMID 34721420, PMID 36094829, PMID 36644348, PMID 37228005, PMID 37426430, PMID 37525369, PMID 39147695, PMID 39372414, PMID 39382091, PMID 40374867
2018 (1), R01HD091185 (1)